Jonathan B. Perlin, Pres-Clinical Operations & CMO at HCA Healthcare, Inc. (HCA), sold 168,031 shares at $147.36 ($2.6M) on 2020-11-09, disclosed to the SEC on 2020-11-09.
Open-market sale of $2.6M HCA by Pres-Clinical Operations & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 50,000 | $0 | 0.0% |
| 2 | $0.00 | 50,000 | $0 | 0.0% |
| 3 | $0.00 | 50,000 | $0 | 0.0% |
| 4 | $137.56 | 6,969 | $959K | 37.0% |
| 5 | $147.36 | 5,531 | $815K | 31.5% |
| 6 | $147.36 | 5,531 |
| $815K |
| 31.5% |
| Total | $15.41 avg | 168,031 | $2.6M | 100% |
| Filing → |
| HCA | SELL | 2020-11-17 | $2.5M | — | Filing → |
| HCA | SELL | 2018-07-27 | $18.8M | — | Filing → |
| HCA | SELL | 2018-06-25 | $1.4M | — | Filing → |